The human lab.

Examines controversial Third World trials of Norplant, a surgically implanted contraceptive which releases a hormone to inhibit ovulation. Witnesses - both patients and doctors - claim that the Bangladesh trials, developed with the aid of the U.S. Agency for International Development, produced serious health problems in the women who took part, that informed consent was not obtained from participants, and that women who requested the removal of Norplant were refused or subjected to brutal handling during its removal. Horizon also examines allegations concerning the management of other implant and vaccine contraceptive trials in Haiti and the Philippines. It investigates the financial backing of such trials and the motives of the U.S. government in permitting them.